Chemoresistant lung cancer

Inhalable nanoliposomes target senescence and overcome chemoresistance in mouse lung cancer

The formulation co-delivers rapamycin and doxorubicin across the mucus barrier to inhibit mTOR and suppress tumor growth without evident systemic toxicity.